flowchart TD
A["Low Frequency Stim"] --> B["Small Ca2+"]
B --> C["Mild NMDA Receptor"]
C --> D["Calcineurin"]
D --> E["PP1 Phosphatase"]
E --> F["AMPA Dephosphorylation"]
F --> G["Endocytosis"]
HAbeta -.->|"Enhance"| G
I["Tau"] -.->|"Disrupt"| D
style H fill:#3b1114,color:#e0e0e0
style I fill:#3b1114,color:#e0e0e0
Long Term Depression (Ltd) In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications. [@malenka2004]
Overview
Long-term depression (LTD) is a type of synaptic plasticity characterized by a persistent weakening of synaptic strength. Unlike [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation)), which strengthens synapses, LTD reduces the efficiency of synaptic transmission. This process is essential for synaptic homeostasis, learning, and memory refinement. However, dysregulation of LTD has been implicated in the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis). [@collingridge2023]
Molecular Mechanisms of LTD Induction
NMDA Receptor-Dependent LTD
...
Long-Term Depression (LTD) in Neurodegeneration
Introduction
Mermaid diagram (expand to render)
Long Term Depression (Ltd) In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications. [@malenka2004]
Overview
Long-term depression (LTD) is a type of synaptic plasticity characterized by a persistent weakening of synaptic strength. Unlike [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation)), which strengthens synapses, LTD reduces the efficiency of synaptic transmission. This process is essential for synaptic homeostasis, learning, and memory refinement. However, dysregulation of LTD has been implicated in the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis). [@collingridge2023]
Molecular Mechanisms of LTD Induction
NMDA Receptor-Dependent LTD
[NMDA receptor](/entities/nmda-receptor)-dependent LTD is the most extensively studied form of LTD. It requires: [@henley2022]
Low-frequency stimulation (1-3 Hz for 10-15 minutes)
Postsynaptic calcium influx through NMDA receptors
Activation of protein phosphatases including [calcineurin](/proteins/calcineurin) and [protein phosphatase 1](/proteins/protein-phosphatase-1)
Dephosphorylation of AMPA receptor subunits
The calcium influx activates [calcium/calmodulin-dependent protein kinase II (CaMKII)](/proteins/camkii), which paradoxically can trigger LTD under low-frequency stimulation conditions through phosphatase activation. [@wang2024]
[mGluR](/therapeutics/metabotropic-glutamate-receptor-therapeutics)-dependent LTD is induced by activation of group I metabotropic glutamate receptors ([mGluR1](/genes/grm1) and [mGluR5](/genes/grm5)). This form of LTD: [@hu2023]
The primary mechanism of LTD expression involves [AMPA receptor](/proteins/ampa-receptor) internalization:
Phosphorylation changes: Dephosphorylation of [GluA1](/genes/gria1) at Ser845 reduces channel conductance
Endocytosis: [Clathrin-mediated endocytosis](/mechanisms/clathrin-mediated-endocytosis) removes AMPA receptors from the synaptic membrane
Trafficking: Internalized receptors are either recycled or targeted for degradation
Scaffolding disruption: Changes in [PSD-95](/proteins/psd95-protein) and other postsynaptic density proteins
Role in Synaptic Homeostasis
LTD serves critical homeostatic functions:
Synaptic scaling: Reduces synaptic strength to prevent overexcitation
Memory erasure: Enables forgetting of unnecessary information
Circuit refinement: Eliminates inappropriate synaptic connections during development
Energy conservation: Reduces metabolic demands of overactive synapses
LTD Dysregulation in Neurodegenerative Diseases
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), LTD mechanisms are profoundly disrupted:
[Amyloid-beta](/proteins/amyloid-beta) ([Aβ](/biomarkers/amyloid-beta-40-abeta-40)) enhances NMDAR-dependent LTD, leading to excessive synaptic weakening
[Tau protein](/mechanisms/tau-pathology) hyperphosphorylation impairs NMDA receptor trafficking and function
Excessive calcium dysregulation ([Calcium dysregulation in AD](/mechanisms/calcium-dysregulation-alzheimers)) lowers the threshold for LTD induction
Synaptic loss correlates with enhanced LTD-like mechanisms
The [amyloid cascade hypothesis](/mechanisms/amyloid-cascade-pathway) now incorporates synaptic plasticity dysregulation including LTD as a key pathogenic mechanism.
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
Striatal medium spiny [neurons](/entities/neurons) show altered LTD mechanisms
Therapeutic Implications
Targeting LTD for Neurodegeneration Treatment
NMDA receptor modulators: Low-dose [memantine](/therapeutics/memantine) normalizes NMDAR function without completely blocking transmission
mGluR5 antagonists: [Basimglurant](/therapeutics/basimglurant) and other mGluR5 negative allosteric modulators
AMPA receptor stabilization: [Perampanel](/therapeutics/perampanel) and related compounds
Calcium homeostasis: [Calcium channel blockers](/therapeutics/calcium-channel-blockers-neurodegeneration) to prevent pathological calcium influx
Protein phosphatase inhibitors: [Okadaic acid](/therapeutics/okadaic-acid) derivatives (experimental)
Challenges
LTD and [LTP](/mechanisms/long-term-potentiation)mechanisms/long-term-potentiation) share many molecular mechanisms, making selective targeting difficult
Normal LTD function is necessary for learning and memory
Temporal regulation is critical—acute vs. chronic LTD dysregulation may require different approaches
Background
The study of Long Term Depression (Ltd) In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research Updates (2024-2026)
Nygren A et al. (2026 Jun 15) [Factors associated with long-term hypnotics use in depression.](https://pubmed.ncbi.nlm.nih.gov/41713603/). J Affect Disord*
Ng HX et al. (2026 Jun 15) [Brain aging in bipolar disorder using a neuroimaging and machine learning-derived metric: Findings from the ENIGMA BD Working Group.](https://pubmed.ncbi.nlm.nih.gov/41587693/). J Affect Disord*
Khanna A et al. (2026 May) [The potential for synergistic effect of non-invasive brain stimulation and cognitive behavioural therapy for depressive and cognitive outcomes in major depressive disorder: A scoping review.](https://pubmed.ncbi.nlm.nih.gov/41722328/). Psychiatry Res*
Xue D et al. (2026 May) [Effects of peer support interventions for family caregivers of persons with dementia: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41690252/). Arch Gerontol Geriatr*
Walter U et al. (2026 Apr 15) [Transcranial sonography of the brainstem raphe: A rapid tool to assess the long-term risk of violent suicidal behavior in patients with major depression.](https://pubmed.ncbi.nlm.nih.gov/41525941/). J Affect Disord*